相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Alzheimer's disease in the omics era
Giulia M. Sancesario et al.
CLINICAL BIOCHEMISTRY (2018)
Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification
Harald Hampel et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2018)
Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
Harald Hampel et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
Bruno Dubois et al.
LANCET NEUROLOGY (2018)
Sex differences in Alzheimer disease - the gateway to precision medicine
Maria Teresa Ferretti et al.
NATURE REVIEWS NEUROLOGY (2018)
Precision pharmacology for Alzheimer's disease
Harald Hampel et al.
PHARMACOLOGICAL RESEARCH (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
Genome-wide association studies of brain imaging phenotypes in UK Biobank
Lloyd T. Elliott et al.
NATURE (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2018)
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update
Erik Portelius et al.
EXPERT REVIEW OF PROTEOMICS (2017)
Are the Origins of Precision Medicine Found in the Corpus Hippocraticum?
Meropi K. Konstantinidou et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease
Patrizia A. Chiesa et al.
TRENDS IN NEUROSCIENCES (2017)
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
Dearbhaile C. Collins et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease
Enrica Cavedo et al.
SCIENTIFIC REPORTS (2017)
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E. O'Bryant et al.
ALZHEIMERS & DEMENTIA (2017)
A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling
H. Hampel et al.
CLIMACTERIC (2017)
Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project
Karen Ritchie et al.
ALZHEIMERS & DEMENTIA (2017)
Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation
Magali Haas et al.
ALZHEIMERS & DEMENTIA (2016)
Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge
Hugo Geerts et al.
ALZHEIMERS & DEMENTIA (2016)
Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease
Enrica Cavedo et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Metabolomics enables precision medicine: A White Paper, Community Perspective
Richard D. Beger et al.
METABOLOMICS (2016)
Journal club ORIGINS OF MASS SPECTROMETRY-BASED PROTEOMICS
Matthias Mann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease
Stefan J. Teipel et al.
NEUROPHARMACOLOGY (2016)
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2015)
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
Sid E. O'Bryant et al.
ALZHEIMERS & DEMENTIA (2015)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Alzheimer's Disease: Mechanism and Approach to Cell Therapy
Takashi Amemori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biomarkers in Sporadic and Familial Alzheimer's Disease
Simone Lista et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline
Simone Lista et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The future of blood-based biomarkers for Alzheimer's disease
Kim Henriksen et al.
ALZHEIMERS & DEMENTIA (2014)
CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
Simone Lista et al.
ALZHEIMERS & DEMENTIA (2014)
Systems Approach to Neurodegenerative Disease Biomarker Discovery
Christopher Lausted et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
Harald Hampel et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Immunotherapy for Alzheimer's disease
Thomas Wisniewski et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Creating Value In Health Care Through Big Data: Opportunities And Policy Implications
Joachim Roski et al.
HEALTH AFFAIRS (2014)
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Piloting IBM Watson Oncology within Memorial Sloan Kettering's regional network
Marjorie Glass Zauderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
USE OF BIOMARKERS AND IMAGING TO ASSESS PATHOPHYSIOLOGY, MECHANISMS OF ACTION AND TARGET ENGAGEMENT
H. Hampel et al.
JOURNAL OF NUTRITION HEALTH & AGING (2013)
Momentum grows to make 'personalized' medicine more 'precise'
Alla Katsnelson
NATURE MEDICINE (2013)
Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease
Stefan J. Teipel et al.
MEDICAL CLINICS OF NORTH AMERICA (2013)
Blood and plasma-based proteomic biomarker research in Alzheimer's disease
Simone Lista et al.
PROGRESS IN NEUROBIOLOGY (2013)
Biological and methodical challenges of blood-based proteomics in the field of neurological research
Simone Lista et al.
PROGRESS IN NEUROBIOLOGY (2013)
Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial
S. M. Mills et al.
REVUE NEUROLOGIQUE (2013)
From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine
Erfan Younesi et al.
EPMA JOURNAL (2013)
Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2012)
Mass Spectrometry-Based Proteomics and Network Biology
Ariel Bensimon et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Revolutionizing medicine in the 21st century through systems approaches
Leroy Hood et al.
BIOTECHNOLOGY JOURNAL (2012)
Mass spectrometry-based proteomics for systems biology
Eduard Sabido et al.
CURRENT OPINION IN BIOTECHNOLOGY (2012)
From inherited to sporadic AD-crossing the biomarker bridge
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2012)
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory
Leroy Hood et al.
NEW BIOTECHNOLOGY (2012)
Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease
Simone Lista et al.
BIOMARKERS IN MEDICINE (2011)
A call to reform the taxonomy of human disease
Ismail Kola et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Present and the Future
Roberta Ghidoni et al.
NEURODEGENERATIVE DISEASES (2011)
The role of genetics for biomarker development in neurodegeneration
Lars Bertram et al.
PROGRESS IN NEUROBIOLOGY (2011)
Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements
Karl Broich et al.
PROGRESS IN NEUROBIOLOGY (2011)
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Michael Ewers et al.
TRENDS IN NEUROSCIENCES (2011)
Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease
Thomas Zetzsche et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2008)
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
R. Ghidoni et al.
NEUROLOGY (2008)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
GPU implementation of neural networks
KS Oh et al.
PATTERN RECOGNITION (2004)
Finishing the euchromatic sequence of the human genome
FS Collins et al.
NATURE (2004)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
分享论文
